PAG
ALXN

Private Advisor Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Private Advisor Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,145
Closed -$761K – 2127
2021
Q2 		$761K Buy
4,145
+1,486
+56% +$255K 0.01% 1201
2021
Q1 		$406K Buy
2,659
+228
+9% +$35.3K ﹤0.01% 1408
2020
Q4 		$380K Buy
+2,431
New +$312K ﹤0.01% 1354
2020
Q3 		– Sell
-890
Closed -$100K – 3826
2020
Q2 		$100K Sell
890
-1,558
-64% -$165K ﹤0.01% 1716
2020
Q1 		$220K Buy
+2,448
New +$240K ﹤0.01% 1198
2019
Q2 		– Sell
-3,066
Closed -$414K – 1747
2019
Q1 		$414K Sell
3,066
-536
-15% -$66.6K 0.01% 1049
2018
Q4 		$347K Sell
3,602
-250
-6% -$29.6K 0.01% 970
2018
Q3 		$535K Sell
3,852
-7,022
-65% -$881K 0.01% 957
2018
Q2 		$1.35M Buy
10,874
+8,536
+365% +$998K 0.02% 387
2018
Q1 		$260K Sell
2,338
-645
-22% -$77.1K 0.01% 951
2017
Q4 		$357K Sell
2,983
-180
-6% -$21.9K 0.02% 820
2017
Q3 		$446K Buy
3,163
+660
+26% +$89.7K 0.01% 945
2017
Q2 		$309K Sell
2,503
-6,451
-72% -$751K 0.01% 1060
2017
Q1 		$281K Buy
8,954
+7,224
+418% +$931K 0.01% 1108
2016
Q4 		$231K Buy
+1,730
New +$212K 0.01% 1081
2016
Q1 		– Sell
-2,394
Closed -$457K – 1158
2015
Q4 		$457K Buy
+2,394
New +$418K 0.02% 623
2015
Q1 		– Sell
-2,235
Closed -$414K – 1089
2014
Q4 		$414K Buy
+2,235
New +$414K 0.03% 608
2014
Q2 		– Sell
-2,541
Closed -$387K – 970
2014
Q1 		$387K Buy
+2,541
New +$404K 0.04% 489

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Private Advisor Group's ALXN Position: Q3 2021 in Review

Private Advisor Group sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 4,145 shares — an estimated $761K sold.

Private Advisor Group first reported a position in ALXN in Q1 2014 and held it in 18 quarters. The position peaked at $1.35M in Q2 2018. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Private Advisor Group reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Private Advisor Group sold 4,145 Alexion Pharmaceuticals shares in Q3 2021, an estimated $761K.
  • Private Advisor Group first reported a position in Alexion Pharmaceuticals in Q1 2014 and held it in 18 quarters.
  • Private Advisor Group's Alexion Pharmaceuticals position peaked at $1.35M in Q2 2018.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Private Advisor Group's 13F filing for Q3 2021, filed 14 Oct 2021.